03.03.2014 Views

How to investigate levels of Adherence to antiretroviral ... - INRUD

How to investigate levels of Adherence to antiretroviral ... - INRUD

How to investigate levels of Adherence to antiretroviral ... - INRUD

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>How</strong> <strong>to</strong> Investigate <strong>Adherence</strong> <strong>to</strong> Antiretroviral Treatment:<br />

An Indica<strong>to</strong>r-Based Approach<br />

Rationale<br />

Source <strong>of</strong> data<br />

Data collection<br />

Computation<br />

Comments<br />

To provide optimal care in line with national policies it is advantageous <strong>to</strong> have<br />

guidelines that can be followed.<br />

Facility interview.<br />

While doing the facility interview ask <strong>to</strong> see copies <strong>of</strong> the different guidelines.<br />

If you can’t hold them in your hand they are not there.<br />

National ART treatment guidelines—The presence <strong>of</strong> a national ART treatment<br />

guidelines.<br />

Donor ART treatment guidelines—The presence <strong>of</strong> a donor ART treatment<br />

guidelines.<br />

ART s<strong>to</strong>rage guidelines—The presence <strong>of</strong> an ART s<strong>to</strong>rage guidelines.<br />

Clinical guidelines for starting patients on ART—Whether the facility manager<br />

says that the facility follows the clinical guidelines for starting patients on ART.<br />

The presence <strong>of</strong> written guidelines does not mean they are being followed.<br />

2. Quality <strong>of</strong> treatment<br />

10. <strong>Adherence</strong> <strong>to</strong> STGs—Percentage <strong>of</strong> patients whose current treatment is consistent<br />

with national STGs<br />

Rationale<br />

Patients treated according <strong>to</strong> established guidelines for ARVs are more likely <strong>to</strong><br />

be adherent <strong>to</strong> care.<br />

Source <strong>of</strong> data Clinical records for the sample <strong>of</strong> 100 patients in indica<strong>to</strong>rs 4–10.<br />

Data collection<br />

Computation<br />

Comments<br />

Patient clinical records are examined <strong>to</strong> determine if current treatment is<br />

consistent with national STG for selection and dosing <strong>of</strong> ARVs.<br />

(Number <strong>of</strong> patients whose last treatment was consistent with STGs/number <strong>of</strong><br />

patients records examined) × 100.<br />

Need <strong>to</strong> prepare a list <strong>of</strong> recommended STG regimens in the system <strong>of</strong> care.<br />

This may be difficult for data collec<strong>to</strong>rs <strong>to</strong> record reliably. In practice, it may be<br />

better <strong>to</strong> record each patient’s regimen for later evaluation.<br />

Number <strong>of</strong> days' supply <strong>of</strong> medicine dispensed<br />

11. The average number <strong>of</strong> days' supply <strong>of</strong> ARVs usually given <strong>to</strong> new patients.<br />

12. The average number <strong>of</strong> days' supply <strong>of</strong> ARVs usually given <strong>to</strong> experienced<br />

patients.<br />

146

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!